JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M412230200 on November 12, 2004

J. Biol. Chem., Vol. 280, Issue 3, 2020-2027, January 21, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/3/2020    most recent
M412230200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Postma, B.
Right arrow Articles by de Haas, C. J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Postma, B.
Right arrow Articles by de Haas, C. J. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Residues 10–18 within the C5a Receptor N Terminus Compose a Binding Domain for Chemotaxis Inhibitory Protein of Staphylococcus aureus*

Bent Postma, Wendy Kleibeuker, Miriam J. J. G. Poppelier, Miranda Boonstra, Kok P. M. Van Kessel, Jos A. G. Van Strijp, and Carla J. C. de Haas{ddagger}

From the Eijkman-Winkler Institute, G04.614, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

Chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) is excreted by the majority of S. aureus strains and is a potent inhibitor of C5a- and formylated peptide-mediated chemotaxis of neutrophils and monocytes. Recently, we reported that CHIPS binds to the C5a receptor (C5aR) and the formylated peptide receptor, thereby blocking activation by C5a and formylated peptides, respectively. The anaphylatoxin C5a plays an important role in host immunity and pathological inflammatory processes. For C5a a two-site binding model is proposed in which C5a initially binds the C5aR N terminus, followed by interaction of the C5a C-terminal tail with an effector domain on the receptor. We have shown here that CHIPS does not affect activation of the C5aR by a peptide mimic of the C5a C terminus. Moreover, CHIPS was found to bind human embryonic kidney 293 cells expressing only the C5aR N terminus. Deletion and mutation experiments within this C5aR N-terminal expression system revealed that the binding site of CHIPS is contained in a short stretch of 9 amino acids (amino acids 10–18), of which the aspartic acid residues at positions 10, 15, and 18 plus the glycine at position 12 are crucial. Binding studies with C5aR/C3aR and C5aR/IL8RA chimeras confirmed that CHIPS binds only to the C5aR N terminus without involvement of its extracellular loops. CHIPS may provide new strategies to block the C5aR, which may lead to the development of new C5aR antagonists.


Received for publication, October 28, 2004 , and in revised form, November 10, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 31-30-2509962; Fax: 31-30-2541770; E-mail: c.j.c.dehaas{at}lab.azu.nl.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Nemali, D. W. Siemsen, L. K. Nelson, P. L. Bunger, C. L. Faulkner, P. Rainard, K. A. Gauss, M. A. Jutila, and M. T. Quinn
Molecular analysis of the bovine anaphylatoxin C5a receptor
J. Leukoc. Biol., August 1, 2008; 84(2): 537 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. H. M. Rooijakkers, F. J. Milder, B. W. Bardoel, M. Ruyken, J. A. G. van Strijp, and P. Gros
Staphylococcal Complement Inhibitor: Structure and Active Sites
J. Immunol., September 1, 2007; 179(5): 2989 - 2998.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-M. Scola, A. Higginbottom, L. J. Partridge, R. C. Reid, T. Woodruff, S. M. Taylor, D. P. Fairlie, and P. N. Monk
The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
J. Biol. Chem., February 9, 2007; 282(6): 3664 - 3671.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel
A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1
J. Immunol., December 1, 2006; 177(11): 8017 - 8026.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
W. J. B. van Wamel, S. H. M. Rooijakkers, M. Ruyken, K. P. M. van Kessel, and J. A. G. van Strijp
The Innate Immune Modulators Staphylococcal Complement Inhibitor and Chemotaxis Inhibitory Protein of Staphylococcus aureus Are Located on {beta}-Hemolysin-Converting Bacteriophages
J. Bacteriol., February 15, 2006; 188(4): 1310 - 1315.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.